Patients consistently had improved glycemic levels and multiple drugs, such as tirzepatide alone or semaglutide in combination with cagrilinitide, were highly effective at promoting weight management
Doctors wrote roughly half a million new anti-obesity GLP-1 scripts between Jan
Expert Opin Drug Discov
When GLP-1 agonists are covered, ACA Marketplace plans almost always employ at least one form of utilization management Among ACA Marketplace plans with these drugs on formulary, prior authorization is required by most plans
Persistent or severe gastrointestinal symptoms while on GLP-1 therapy, such as severe nausea, vomiting, diarrhea, or severe abdominal pain, should prompt immediate medical evaluation
Archived from the original (PDF) on 7 November 2022